Antitumor Effect of Trastuzumab for Pancreatic Cancer with High HER-2 Expression and Enhancement of Effect by Combined Therapy with Gemcitabine-Reference-Cited by-同舟云学术

Antitumor Effect of Trastuzumab for Pancreatic Cancer with High HER-2 Expression and Enhancement of Effect by Combined Therapy with Gemcitabine

Published:2006-08-15 Issue:16 Volume:12 Page:4925-4932
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Kimura Kenjiro,Sawada Tetsuji,Komatsu Midori,Inoue Masafumi,Muguruma Kazuya,Nishihara Tamahiro,Yamashita Yoshito,Yamada Nobuya,Ohira Masaichi,Hirakawa Kosei

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer organoids;Frontiers in Immunology;2023-07-14

2. Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2–Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates;JCO Precision Oncology;2023-04

3. Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer—The CONKO-008 Phase I Investigation;Journal of Clinical Medicine;2022-08-21

4. A special subtype: Revealing the potential intervention and great value of KRAS wildtype pancreatic cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-07

5. Complete remission in a patient with widely metastatic HER2-amplified pancreatic adenocarcinoma following multimodal therapy informed by tumor sequencing and organoid profiling;2021-12-21